A carregar...
Precision therapy for acute myeloid leukemia
Acute myeloid leukemia (AML) is a molecularly and clinically heterogeneous disease. Despite advances in understanding the pathogenesis of AML, the standard therapy remained nearly unchanged over the past three decades. With the poor survival for older patients and high relapse rate, multiple studies...
Na minha lista:
| Publicado no: | J Hematol Oncol |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
BioMed Central
2018
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5755341/ https://ncbi.nlm.nih.gov/pubmed/29301553 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13045-017-0543-7 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|